Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
EXAGEN INC.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
EXAGEN INC.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
EXAGEN INC.Listing on record | Buy | $14K | conv 61First in 12mo | SEC | |
OnKure Therapeutics, Inc.Listing on record | Sell | $949.8K | SEC | ||
OnKure Therapeutics, Inc.Listing on record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
OnKure Therapeutics, Inc.Listing on record | Exercise | $220.1K | SEC | ||
EXAGEN INC.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
EXAGEN INC.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Armata Pharmaceuticals, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Armata Pharmaceuticals, Inc.Listing on record | Buy | $4.4K | conv 74First in 12mo | SEC | |
Armata Pharmaceuticals, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Armata Pharmaceuticals, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |